124 related articles for article (PubMed ID: 28742189)
1. Novel endogenous negative modulators of platelet function as potential anti-thrombotic targets.
Li YJ; Zhu HX; Zhang D; Li HC; Ma P; Huang LY
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3146-3158. PubMed ID: 28742189
[TBL] [Abstract][Full Text] [Related]
2. RXR Ligands Negatively Regulate Thrombosis and Hemostasis.
Unsworth AJ; Flora GD; Sasikumar P; Bye AP; Sage T; Kriek N; Crescente M; Gibbins JM
Arterioscler Thromb Vasc Biol; 2017 May; 37(5):812-822. PubMed ID: 28254816
[TBL] [Abstract][Full Text] [Related]
3. CLP36 is a negative regulator of glycoprotein VI signaling in platelets.
Gupta S; Braun A; Morowski M; Premsler T; Bender M; Nagy Z; Sickmann A; Hermanns HM; Bösl M; Nieswandt B
Circ Res; 2012 Nov; 111(11):1410-20. PubMed ID: 22955732
[TBL] [Abstract][Full Text] [Related]
4. Endogenous inhibitory mechanisms and the regulation of platelet function.
Jones CI; Barrett NE; Moraes LA; Gibbins JM; Jackson DE
Methods Mol Biol; 2012; 788():341-66. PubMed ID: 22130718
[TBL] [Abstract][Full Text] [Related]
5. Roles of Src-like adaptor protein 2 (SLAP-2) in GPVI-mediated platelet activation SLAP-2 and GPVI signaling.
Sugihara S; Katsutani S; Deckmyn H; Fujimura K; Kimura A
Thromb Res; 2010 Oct; 126(4):e276-85. PubMed ID: 20828795
[TBL] [Abstract][Full Text] [Related]
6. Ginsenoside-Rp3 inhibits platelet activation and thrombus formation by regulating MAPK and cyclic nucleotide signaling.
Irfan M; Jeong D; Kwon HW; Shin JH; Park SJ; Kwak D; Kim TH; Lee DH; Park HJ; Rhee MH
Vascul Pharmacol; 2018 Oct; 109():45-55. PubMed ID: 29890296
[TBL] [Abstract][Full Text] [Related]
7. Mice Lacking PECAM-1 and Ceacam1 Have Enhanced Platelet Secretion and Thrombus Growth: Novel Link with PAR4.
Kuriri FA; Burchall G; Alanazi F; Antonipillai J; Dobie G; Beachemin N; Jackson DE
Thromb Haemost; 2022 Jun; 122(6):961-973. PubMed ID: 34619794
[TBL] [Abstract][Full Text] [Related]
8. Platelets possess and require an active protein palmitoylation pathway for agonist-mediated activation and in vivo thrombus formation.
Sim DS; Dilks JR; Flaumenhaft R
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1478-85. PubMed ID: 17303775
[TBL] [Abstract][Full Text] [Related]
9. P2 receptors, platelet function and pharmacological implications.
Gachet C
Thromb Haemost; 2008 Mar; 99(3):466-72. PubMed ID: 18327393
[TBL] [Abstract][Full Text] [Related]
10. Role of platelets in atherothrombosis.
Jennings LK
Am J Cardiol; 2009 Feb; 103(3 Suppl):4A-10A. PubMed ID: 19166707
[TBL] [Abstract][Full Text] [Related]
11. Molecular Drivers of Platelet Activation: Unraveling Novel Targets for Anti-Thrombotic and Anti-Thrombo-Inflammatory Therapy.
Chatterjee M; Ehrenberg A; Toska LM; Metz LM; Klier M; Krueger I; Reusswig F; Elvers M
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114406
[TBL] [Abstract][Full Text] [Related]
12. Phosphotyrosine signaling in platelets: lessons for vascular thrombosis.
Wee JL; Jackson DE
Curr Drug Targets; 2006 Oct; 7(10):1265-73. PubMed ID: 17073587
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet action of indirubin-3'-monoxime through suppression of glycoprotein VI-mediated signal transduction: a possible role for ERK signaling in platelets.
Lee JJ; Han JH; Jung SH; Lee SG; Kim IS; Cuong NM; Huong TT; Khanh PN; Kim YH; Yun YP; Ma JY; Myung CS
Vascul Pharmacol; 2014 Dec; 63(3):182-92. PubMed ID: 25451564
[TBL] [Abstract][Full Text] [Related]
14. Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2.
Inoue O; Suzuki-Inoue K; Dean WL; Frampton J; Watson SP
J Cell Biol; 2003 Mar; 160(5):769-80. PubMed ID: 12615912
[TBL] [Abstract][Full Text] [Related]
15. The P2 receptors in platelet function.
Hechler B; Cattaneo M; Gachet C
Semin Thromb Hemost; 2005 Apr; 31(2):150-61. PubMed ID: 15852218
[TBL] [Abstract][Full Text] [Related]
16. Aerobic glycolysis fuels platelet activation: small-molecule modulators of platelet metabolism as anti-thrombotic agents.
Kulkarni PP; Tiwari A; Singh N; Gautam D; Sonkar VK; Agarwal V; Dash D
Haematologica; 2019 Apr; 104(4):806-818. PubMed ID: 30381300
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
[TBL] [Abstract][Full Text] [Related]
18. P2Y12 receptor in platelet activation.
Kim S; Kunapuli SP
Platelets; 2011; 22(1):56-60. PubMed ID: 21231822
[TBL] [Abstract][Full Text] [Related]
19. Activation of porcine endothelium in response to xenogeneic serum causes thrombosis independently of platelet activation.
Galbusera M; Buelli S; Gastoldi S; Macconi D; Angioletti S; Testa C; Remuzzi G; Morigi M
Xenotransplantation; 2005 Mar; 12(2):110-20. PubMed ID: 15693841
[TBL] [Abstract][Full Text] [Related]
20. Platelet adhesion signalling and the regulation of thrombus formation.
Gibbins JM
J Cell Sci; 2004 Jul; 117(Pt 16):3415-25. PubMed ID: 15252124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
